Julémont F - Search Results

1

N-(3-Phenoxy-4-pyridinio)methanesulfonamidate.

Michaux C, Charlier C, Julémont F, Dogné JM, de Leval X, Norberg B, Pirotte B, Durant F. Michaux C, et al. Among authors: julemont f. Acta Crystallogr C. 2002 Feb;58(Pt 2):o88-9. doi: 10.1107/s0108270101018595. Epub 2002 Jan 23. Acta Crystallogr C. 2002. PMID: 11828118

2

A new potential cyclooxygenase-2 inhibitor, pyridinic analogue of nimesulide.

Michaux C, Charlier C, Julémont F, de Leval X, Dogné JM, Pirotte B, Durant F. Michaux C, et al. Among authors: julemont f. Eur J Med Chem. 2005 Dec;40(12):1316-24. doi: 10.1016/j.ejmech.2005.08.003. Epub 2005 Oct 11. Eur J Med Chem. 2005. PMID: 16225966

3

Structure-based pharmacophore of COX-2 selective inhibitors and identification of original lead compounds from 3D database searching method.

Michaux C, de Leval X, Julémont F, Dogné JM, Pirotte B, Durant F. Michaux C, et al. Among authors: julemont f. Eur J Med Chem. 2006 Dec;41(12):1446-55. doi: 10.1016/j.ejmech.2006.07.017. Epub 2006 Oct 9. Eur J Med Chem. 2006. PMID: 17030482

4

Spectral and crystallographic study of pyridinic analogues of nimesulide: determination of the active form of methanesulfonamides as COX-2 selective inhibitors.

Julémont F, de Leval X, Michaux C, Damas J, Charlier C, Durant F, Pirotte B, Dogné JM. Julémont F, et al. J Med Chem. 2002 Nov 7;45(23):5182-5. doi: 10.1021/jm020920n. J Med Chem. 2002. PMID: 12408728

5

Design, synthesis, and pharmacological evaluation of pyridinic analogues of nimesulide as cyclooxygenase-2 selective inhibitors.

Julémont F, de Leval X, Michaux C, Renard JF, Winum JY, Montero JL, Damas J, Dogné JM, Pirotte B. Julémont F, et al. J Med Chem. 2004 Dec 30;47(27):6749-59. doi: 10.1021/jm049480l. J Med Chem. 2004. PMID: 15615524

6

Synthesis, molecular modelling and enzymatic evaluation of (+/-)3,5-diphenyl-2-thioxoimidazolidin-4-ones as new potential cyclooxygenase inhibitors.

Gauthier MP, Michaux C, Rolin S, Vastersaegher C, de Leval X, Julémont F, Pochet L, Masereel B. Gauthier MP, et al. Among authors: julemont f. Bioorg Med Chem. 2006 Feb 15;14(4):918-27. doi: 10.1016/j.bmc.2005.09.005. Epub 2005 Oct 7. Bioorg Med Chem. 2006. PMID: 16214349

7

First and second generations of COX-2 selective inhibitors.

de Leval X, Julémont F, Benoit V, Frederich M, Pirotte B, Dogné JM. de Leval X, et al. Among authors: julemont f. Mini Rev Med Chem. 2004 Aug;4(6):597-601. doi: 10.2174/1389557043403693. Mini Rev Med Chem. 2004. PMID: 15279593 Review.

8

Recent development in the field of dual COX / 5-LOX inhibitors.

Julémont F, Dogné JM, Pirotte B, de Leval X. Julémont F, et al. Mini Rev Med Chem. 2004 Aug;4(6):633-8. doi: 10.2174/1389557043403747. Mini Rev Med Chem. 2004. PMID: 15279597 Review.

9

The use of nimesulide and its analogues in cancer chemoprevention.

Renard JF, Julémont F, de Leval X, Pirotte B. Renard JF, et al. Among authors: julemont f. Anticancer Agents Med Chem. 2006 May;6(3):233-7. doi: 10.2174/187152006776930855. Anticancer Agents Med Chem. 2006. PMID: 16712451 Review.

10

New trends in dual 5-LOX/COX inhibition.

Leval Xd, Julemont F, Delarge J, Pirotte B, Dogne JM. Leval Xd, et al. Among authors: julemont f. Curr Med Chem. 2002 May;9(9):941-62. doi: 10.2174/0929867024606713. Curr Med Chem. 2002. PMID: 11966455 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

11 results

Search Page